阿斯利康承诺在华投资150亿美元,增强细胞疗法与放射性药物研发能力。
AstraZeneca vows $15B China investment to boost cell therapy and radioconjugate capabilities
生物技术与制药领域的最新动态
AstraZeneca vows $15B China investment to boost cell therapy and radioconjugate capabilities
A GPCR-G protein-β-arrestin megacomplex enabled by a versatile allosteric modulator
Field-effect-informed urine liquid biopsy for bladder cancer
AAVLINK: A potent DNA-recombination method for large cargo delivery in gene therapy
An uORF-encoded mobile peptide sparks systemic stomatal immunity
A triple-node heart-brain neuroimmune loop underlying myocardial infarction
Mast cells promote pathology and susceptibility in tuberculosis
Capsule Techs Expand Possibilities for Experiments on Single Cells - GenomeWeb
Single-Cell Genome Sequencing Market Is Going to Boom |• 10x Genomics • Illumina - openPR.com
Catalent plans to close Belgium cell therapy site
Dose-dependent activation of the Hippo pathway by Type I and Type III interferons suppresses tissue repair by human bronchial epithelial cells
The crucial role of raw material selection for success in cell therapy manufacturing
PIKFYVE inhibition mitigates disease in models of diverse forms of ALS
Can H5N1 avian influenza in dairy cattle be contained in the US?
Illumina’s billion cell atlas tries to solve artificial intelligence’s data bottleneck in biology - 2 Minute Medicine
Illumina’s billion cell atlas tries to solve artificial intelligence’s data bottleneck in biology - 2 Minute Medicine
Overexpression of the pioneer transcription factor Nr5a2 promotes the development of mouse somatic cell nuclear transfer embryos
Cell Therapy Bioprocessing Market Is Going to Boom |• Lonza • Thermo Fisher Scientific - openPR.com
HIV-specific CD8+ T-cell proliferative response 24 weeks after early antiretroviral therapy initiation is associated with the subsequent reduction in the viral reservoir
Robust assessment of asymmetric division in colon cancer cells